Medical Practices: Payer Mix and Reimbursement

Executive Summary (TL;DR)

• If you’re trying to buy a medical practice, payer mix is not a “detail”—it’s a primary driver of sustainable cash flow and financing readiness.
• Underwrite reimbursement realism, not headline collections: look at contracted rates, denials, write-offs, and time-to-collect by payer.
• Normalize profitability by separating provider compensation from true owner earnings (SDE vs. EBITDA) and stress-test downside scenarios.
• Move through a disciplined process (NDA → LOI → diligence → close) with a healthcare-specific diligence focus: credentialing, compliance, billing integrity, and referral/payer concentration.
• Buyers/investors should act next by building a “payer-first” diligence checklist and comparing multiple opportunities side-by-side on a consistent underwriting template.

Table of Contents

• Why payer mix and reimbursement matter right now
• What buyers/investors should do next
• Valuation lens for medical practices
• Deal process overview: NDA → LOI → diligence → close
• Due diligence checklist (with table)
• Decision matrix: when payer mix risk is acceptable
• Myth vs. Fact: medical practice reimbursement
• 30/60/90-day execution plan for buyers
• Next steps on BizTrader

Why payer mix and reimbursement matter right now

If your acquisition thesis depends on stable collections, you can’t treat payer mix like a footnote. “Payer mix” is the percentage of revenue (or encounters) coming from Medicare, Medicaid, commercial payers, cash/self-pay, workers’ compensation, or other programs. Each bucket has different reimbursement rules, contracting dynamics, denial behavior, and patient retention patterns—so the mix often determines whether the practice behaves like a predictable annuity or a volatile receivables business.

If you’re starting your search, begin where deal flow is broad and filterable: browse the Businesses for sale marketplace, then narrow to healthcare opportunities that match your operator profile, geography, and licensing requirements.

The “reimbursement engine” you’re buying

A medical practice’s revenue system is usually a chain:

1. Patient demand and scheduling
2. Clinical documentation
3. Coding (e.g., CPT/HCPCS) and claim submission
4. Payer adjudication (allowed amount, patient responsibility, denials)
5. Collections (patient, secondary payer)
6. Write-offs and adjustments
7. Post-payment audits, recoupments, and appeals

Payer mix affects every link in that chain. It influences:

• Allowed amounts (what the payer will pay for a service)
• Administrative friction (prior auth, documentation burden)
• Denial rates and rework costs
• Days in A/R (accounts receivable)
• Patient responsibility and bad-debt exposure
• Regulatory scrutiny and audit risk, depending on program

For Medicare physician services, reimbursement mechanics are tied to the Medicare Physician Fee Schedule, which uses concepts like relative value units (RVUs) and is updated on a recurring basis by the Centers for Medicare & Medicaid Services (CMS).

What buyers/investors should do next

When people search “buy medical practice payer mix,” they often jump straight to “What percentage commercial vs. Medicare is good?” That’s the wrong first question. The right first question is: How sensitive is normalized cash flow to payer-driven variability?

Here’s a buyer-first sequence that works in real deals:

1) Ask for a payer mix report that matches collections—not just visits

Insist on a payer mix view by:

• Collections (cash received)
• Gross charges
• Allowed amounts
• Adjustments/write-offs
• Patient responsibility and actual patient collections

A practice can look “commercial-heavy” on charges and still be “Medicare-heavy” on collections (or vice versa). Underwrite to cash.

2) Underwrite reimbursement quality, not just reimbursement level

Two practices with the same payer mix can perform wildly differently because of:

• Contracted fee schedules vs. “out of network” collections
• Denial management maturity
• Patient balance collection policies
• Documentation and coding accuracy
• Concentration in a single payer or plan variant (a hidden “customer concentration”)

3) Separate operational value from owner-specific economics

Most Main Street medical practices are marketed using SDE (Seller Discretionary Earnings)—earnings available to a single owner-operator after adding back discretionary or non-recurring expenses (“add-backs”). Larger or multi-provider groups may be discussed using EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization).

For healthcare, the critical normalization is usually provider compensation:

• What is “market” compensation for physician/APP production?
• Is the seller underpaying themselves (inflating profits) or overpaying themselves (deflating profits)?
• Are there personal add-backs embedded in payroll, travel, or auto?

4) Stress-test three scenarios before you fall in love

Build a simple model that can run:

• Base case (current run-rate)
• Downside case (reimbursement pressure + higher denials + slower collections)
• Operational improvement case (better revenue cycle management, scheduling optimization)

You don’t need perfect forecasting—just a disciplined way to see whether the deal still works if reimbursement or payer behavior moves against you.

5) Decide early how you’ll structure risk: price, terms, or both

In healthcare, it’s common to use structure as a risk valve:

• Seller note (seller financing) to bridge valuation gaps and align incentives
• Earnout tied to post-close collections or patient retention (use carefully—collections-based earnouts can create disputes if revenue cycle processes change)
• Working capital targets to prevent you from “buying” a cash crunch

Valuation lens for medical practices

Valuing a medical practice is less about a single multiple and more about durability of earnings. Payer mix is a durability variable.

The practical equation

Normalized cash flow = (sustainable collections) – (true operating costs) – (market provider comp) ± (reasonable add-backs)

From there, multiples (whether SDE-based or EBITDA-based) are influenced by:

• Provider dependency (Is revenue tied to one physician?)
• Referral concentration (a few sources driving a large share of volume)
• Payer concentration (one plan or one payer dominating collections)
• Staffing stability and productivity
• Compliance cleanliness (billing integrity, documentation support)
• Facility/lease stability and landlord consent risk for assignment
• Systems maturity (EHR, billing platform, KPI reporting)

Reimbursement and payer mix signals that change your multiple

Buyers tend to pay more (or require fewer protective terms) when they see:

• Contracted rates documented and not overly dependent on one payer contract
• Stable or improving collections per visit/RVU
• Low rework: denials addressed quickly, clean claims, consistent coding
• Healthy A/R aging and a clear explanation of “old A/R”
• Minimal recoupments, refunds, or payer disputes

Buyers tend to pay less (or demand more structure) when they see:

• Rising denials with no root-cause plan
• High adjustments/write-offs without explanation
• A/R spikes, frequent payer delays, or heavy patient-balance exposure
• Unclear credentialing/enrollment status for providers and locations
• Significant reliance on one payor, one employer group, or one referral source

Deal process overview: NDA → LOI → diligence → close

Healthcare deals follow the same spine as other SMB acquisitions, but the “organs” are different.

NDA (Non-Disclosure Agreement)

Before receiving a full CIM (Confidential Information Memorandum) or detailed billing/financial reports, you’ll sign an NDA. In medical practices, you may also need to agree to additional confidentiality constraints around patient information and compliance.

LOI (Letter of Intent)

Your LOI should specify (at a high level):

• Price and structure (cash, seller note, earnout)
• Whether it’s an asset vs. stock sale
• What working capital is included or targeted
• Non-compete and non-solicit expectations
• Transition period (how long the seller stays, what they do)
• Diligence scope and timeline

Diligence

This is where payer mix and reimbursement become “real.” You’re validating:

• Financial quality (and whether a QoE (Quality of Earnings) review is warranted)
• Billing integrity and revenue cycle performance
• Compliance risk (including screening vendors/individuals against exclusions lists)
• Contracts: payor agreements, lease, major vendors
• Operational continuity: staff, scheduling, systems, clinical workflows
• Legal/encumbrance checks (e.g., UCC/lien search on equipment)

For exclusion screening, the U.S. Department of Health and Human Services Office of Inspector General (OIG) maintains the List of Excluded Individuals/Entities (LEIE), and hiring/contracting with excluded parties can create significant risk.

Close

At closing, ensure the purchase agreement (often called an APA/SPA) covers:

• Reps & warranties (what the seller is asserting is true)
• Indemnities (how issues are handled post-close)
• Allocation of purchase price (important for taxes, especially in asset sales)
• Transition obligations and handoff of payer-related workflows

For certain asset transactions, both buyer and seller may need to report an allocation of the purchase price to the IRS (commonly via Form 8594 when applicable).

Due diligence checklist (with table)

Use a secure data room (virtual data room) so you can track versions and keep a clean diligence trail. Below is a buyer-grade checklist focused on payer mix and reimbursement.

Diligence area	What to request	Why it matters	Common red flags
Payer mix (collections-based)	24–36 months payer mix by collections, charges, allowed, adjustments	Reveals true cash composition and sensitivity	Mix reported only by visits or charges
Contracted rates & fee schedules	Payor contracts, fee schedules, “in-network” proof	Confirms revenue assumptions	Missing contracts; “verbal” rate claims
A/R aging & reconciliation	A/R aging by payer + tie-out to GL	Validates collectability and working capital	Old A/R ballooning; large unexplained “other”
Denials & appeals	Denial rate trends, top denial codes, appeal outcomes	Measures friction and hidden labor cost	Denials rising; no root-cause analytics
Refunds/recoupments	History of payer recoupments, refunds, audits	Indicates compliance and revenue integrity	Frequent take-backs; open audits
Coding/documentation	Coding policies, chart audit summaries (de-identified), training logs	Protects against overcoding/undercoding risk	No audits; heavy reliance on one biller
Provider productivity	Visits/RVUs/collections per provider, schedule templates	Normalizes provider comp and capacity	Production concentrated in one provider
Credentialing/enrollment	Provider enrollment status by payer and location	Prevents post-close reimbursement gaps	Enrollment “in process” with no timeline
Referral concentration	Top referral sources and percentages	Identifies demand fragility	One source drives outsized volume
Patient responsibility	Patient collections rate, policy, payment plans	Predicts bad debt and cash timing	High patient AR; weak collection policy
Staffing & billing ops	Org chart, billing vendor terms, KPIs	Ensures continuity and cost clarity	Key-person dependency; vendor lock-in
Lease & premises	Lease, assignment clause, landlord consent needs	Avoids location disruption	Non-assignable lease; short remaining term
Liens & obligations	UCC/lien search, equipment schedules, debts	Ensures clean title to assets	Liens on critical equipment
Deal structure	Asset vs. stock, seller note, earnout terms	Allocates risk to match uncertainty	Earnout triggers that can’t be measured

To keep your search organized, it helps to benchmark similar listings and diligence expectations within a focused category like Medical practices for sale.

Decision matrix: when payer mix risk is acceptable

Not all “risky” payer mix is bad—sometimes it’s just mispriced, mismanaged, or misunderstood. Use this matrix to decide whether you fix it, price it, or walk away.

Situation	What it usually means	Buyer-friendly move
High single-payer concentration	“Customer concentration” in disguise	Reduce price or require seller note/holdback
Heavy patient responsibility	Collections depend on patient pay behavior	Underwrite higher bad debt + improve front-end collections
Rates unclear / contracts missing	Revenue not provable	Make LOI contingent on contract verification
Denials rising	Revenue cycle weakness or payer policy shifts	Require KPI improvement plan + adjust working capital target
Medicare-heavy but clean ops	Predictable rules, strong compliance needed	Focus on documentation discipline; price for stability
Mixed payers + strong RCM	Operational resilience	Pay closer to market—less structure needed

If you’re actively screening deals with different operator involvement levels, a parallel view of investor-style opportunities (where management depth matters) can help—see Absentee owner listing highlights for comparison.

Myth vs. Fact: medical practice reimbursement

• Myth: “Great payer mix automatically means great profit.”
  Fact: Profit comes from net collections after denials, write-offs, and overhead, not payer labels.
• Myth: “Commercial is always better than Medicare.”
  Fact: Commercial can pay more, but it can also be more variable (contract changes, prior auth, denials). Medicare mechanics are formalized and widely referenced, but still require discipline and compliance.
• Myth: “Collections are stable if the patient base is stable.”
  Fact: Collections stability depends on payer behavior, coding/documentation, and revenue cycle execution—not just patient volume.
• Myth: “A clean P&L proves billing is clean.”
  Fact: Financial statements don’t prove coding/documentation support. Billing integrity needs its own diligence track.
• Myth: “You can fix reimbursement after closing.”
  Fact: Some fixes take time (credentialing/enrollment, contract negotiations, staffing). Treat timing as a cash-flow risk, not a to-do list.

30/60/90-day execution plan for buyers

First 30 days: build your underwriting spine

• Define your target profile: specialty, location, provider count, your clinical/ops capabilities
• Create a standard request list (payer mix, A/R, denials, contracts, provider productivity)
• Build a one-page model template: base/downside/improvement
• Prepare diligence routing: attorney, CPA, healthcare billing expert (as needed)

If you need a structured overview of the broader acquisition steps (beyond healthcare specifics), keep this handy: BizTrader’s guide to buying and selling businesses.

Days 31–60: go deep on the top 1–2 targets

• Sign NDA, review CIM, run first-pass underwriting
• Validate payer mix against bank deposits and A/R movement
• Pressure-test provider dependency and referral concentration
• Identify “fixable vs. structural” reimbursement issues
• Draft LOI terms that match the risk (price, seller note, earnout, working capital)

Days 61–90: diligence to decision and close-readiness

• Confirm contracts, enrollment/credentialing path, and billing workflows
• Run lien checks (UCC), verify lease assignability and landlord consent timing
• Finalize definitive agreement: reps & warranties, indemnities, transition period
• Lock transition plan: seller involvement, staff retention, operational KPIs
• Create a post-close “first 100 days” revenue cycle plan (denials, front desk, coding audits)

Next steps on BizTrader

If you’re actively evaluating opportunities and want to keep payer mix front-and-center:

• Start broad, then filter: explore Businesses for sale and save a short list you can underwrite consistently.
• Go category-specific: compare similar opportunities under Medical practices for sale to spot what’s truly “market.”
• Build your deal team: connect with professionals through Business brokers and run a disciplined diligence process before you commit.

This article is for educational purposes only and does not constitute legal, financial, tax, or business brokerage advice. Always consult qualified professionals before making decisions, and verify all requirements with the appropriate authorities and counterparties.